Changes / RenewalRSSAbout RSS
- May 19, 2026 Release Positive Interim Analysis Results from Phase 3 Clinical Trial of Tapinarof Cream 0.5%,Aryl Hydrocarbon Receptor (AhR) Modulating Agent,in Infant Patients with Atopic Dermatitis in Japan（PDF）
- May 7, 2026 Information " Creating Supportive Workplaces " was updated.
- April 27, 2026 Release Announcement Regarding Absorption-Type Merger of Torii by Shionogi & Co., Ltd.（PDF）
- February 27, 2026 Release Application for Manufacturing and Marketing Approval of a New Lotion Formulation for the Atopic Dermatitis Treatment "CORECTIM®" in Japan（PDF）
- February 20, 2026 Release Announcement of Decision on Basic Policy Regarding Absorption-Type Merger of Torii by Shionogi & Co., Ltd.（PDF）